Category Jumplist
Jumplist
- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in COVAXIN Phase 3
Covaxin Shows Robust Safety & Immunogenicity In Children 2-18 Years
Bharat Biotech International Limited (BBIL), a global developer of vaccines for infectious diseases, today announced that BBV152 (COVAXINÒ), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study.
Read MoreCOVID-19: Phase 3 of COVAXIN to check its effectiveness to prevent disease
COVID-19: Phase 3 of COVAXIN to check its effectiveness to prevent disease
Read More